Promising antifungal properties of the orally active autophagy inhibitor SBP-7455 against fluconazole-resistant Candida clinical isolates.
Sign Up to like & getrecommendations! Published in 2025 at "Letters in applied microbiology"
DOI: 10.1093/lambio/ovaf055
Abstract: Candida species, the single most common cause of fungal infections, are major opportunistic pathogens. Novel antifungal agents are needed to address the threat of Candida infections resistant to first-line antifungal agents and those that are… read more here.
Keywords: sbp 7455; autophagy inhibitor; sbp; fluconazole resistant ... See more keywords